| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Aug 24 | CERE Cerevel Therapeutics | Common Stock | Sale back to company | Dispose D | Yes | No | 0 | 65,679,781 | 0.00 | 0 |
| 1 Aug 24 | CERE Cerevel Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 10,461 | 0.00 | 0 |
| 1 Aug 24 | CERE Cerevel Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 3,282 | 0.00 | 10,461 |
| 1 Aug 24 | CERE Cerevel Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0 | 80,189 | 0.00 | 0 |
| 26 Jun 24 | FHTX Foghorn Therapeutics | Stock Options Common Stock | Grant | Acquire A | No | No | 5.52 | 16,000 | 88.32 k | 16,000 |
| 5 Jun 24 | CERE Cerevel Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 10,461 | 0.00 | 13,743 |
| 11 Jan 24 | SLDB Solid Biosciences | Common Stock | Grant | Acquire A | Yes | No | 5.53 | 904,160 | 5.00 mm | 4,034,582 |
